DALLAS, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback